Correlation Engine 2.0
Clear Search sequence regions


  • cellular (1)
  • control groups (1)
  • CTGF (1)
  • Il 6 (1)
  • joint diseases (1)
  • losartan (11)
  • motion (1)
  • myofibroblast (1)
  • other organs (1)
  • phase (1)
  • placebo (1)
  • rat (4)
  • TGF β (1)
  • traumatic (8)
  • Sizes of these terms reflect their relevance to your search.

    Post-traumatic joint stiffness (PTJS) is accompanied by a multidimensional disturbance of joint architecture. Pharmacological approaches represent promising alternatives as the traumatic nature of current therapeutic standards may lead to PTJS' progression. Losartan is an auspicious candidate, as it has demonstrated an antifibrotic effect in other organs. Forty-eight Sprague Dawley rats were randomized into equally sized losartan or control groups. After a standardized knee trauma, the joint was immobilized for either 2 weeks (n = 16), 4 weeks (n = 16) or 4 weeks with re-mobilization for an additional 4 weeks (n = 16). Pharmacotherapy with losartan or placebo (30 mg/kg/day) was initiated on the day of trauma and continued for the entire course. Joint contracture was measured alongside histological and molecular biological assessments. There were no significant biomechanical changes in joint contracture over time, comparing short-term (2 weeks) with long-term losartan therapy (4 weeks). However, comparing the formation of PTJS with that of the control, there was a trend toward improvement of joint mobility of 10.5° (p 0.09) under the influence of losartan. During the re-mobilization phase, no significant effect of losartan on range of motion (ROM) was demonstrated. At a cellular level, losartan significantly reduced myofibroblast counts by up to 72 % (4 weeks, p ≤ 0.001) without effecting the capsular configuration. Differences in expression levels of profibrotic factors (TGF-β, CTGF, Il-6) were most pronounced at week 4. The antifibrotic properties of losartan are not prominent enough to completely prevent the development of PTJS after severe joint injury. Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

    Citation

    Erik Wegner, Tim Mickan, Sebastian Truffel, Ekaterina Slotina, Lukas Müller, Felix Wunderlich, Austin Harper, Ulrike Ritz, Pol M Rommens, Erol Gercek, Philipp Drees, Andreas Baranowski. The effect of losartan on the development of post-traumatic joint stiffness in a rat model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023 Oct;166:115291

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37557010

    View Full Text